Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-17

Clinical Trial Update: Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of Drug Eluting Beads Transarterial Chemoembolization in Egyptian patients with hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drug Eluting Beads Transarterial Chemoembolization (Drug Eluting Beads TACE)

Snippet

Sponsor: Ain Shams University | Conditions: HepatoCellular Carcinoma | Phase 4 | Status: COMPLETED | Results posted: 2020-09-17